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ABSTRACT
Rabies encephalitis is a fatal zoonotic viral disease transmitted to humans either by 
domestic animals like dogs and cats or by wild animals like bats, skunks and raccoons. We 
present the case of a 25-year-old woman admitted due to behavioral disorders, generalized 
paresthesiasand acute respiratory deterioration compatible with a respiratory distress syndrome 
(ARDS) requiring orotracheal intubation, mechanical ventilation and empirical initiation of 
antibiotic and antiviral therapy. Chest tomography showed pneumomediastinum and changes 
suggestive of pulmonary infection. In the presence of neurological symptoms, a central nervous 
system (CNS) infection was suspected and the cerebrospinal fluid showed no pleocytosis, 
hiperproteinorrachy without glucose consumption; cranial CT scan was normal. During 
hospitalization, the family reported that the patient was bitten by a cat 30-day prior to the onset 
of rabies-like symptoms, and the animal was sacrificed. The patient had an unfavorable clinical 
evolution, with electroencephalographic activity dissociation evidenced by video telemetry. 
The zoonotic exposure led to the suspected diagnosis of rabies infection. The patient died and 
the suspected diagnosis was confirmed by histopathology, with presence of Negri bodies on 
cerebellum Purkinje cells and a positive immunofluorescence test for rabies virus. Both, initial 
extra-neural manifestations and late reporting of rabies exposure led to delayed diagnosis. 
KEYWORDS: Rabies. Encephalitis. Zoonoses. Severe acute respiratory syndrome. Extra-
neural manifestations. 
INTRODUCTION
Rabies is a zoonotic disease, with worldwide distribution, except for Antarctica; 
annual human cases are estimated to be around 75,000, with highest incidence rates 
reported in Asia and Africa1,2. In Colombia, rabies is in the list of notifiable diseases 
since 1970, and there is a specific strategic plan for the elimination of human rabies 
transmitted by dogs or bats, which has resulted in a significant reduction of human 
cases3,4.
Rabies virus is a Lyssavirus of the Rhabdoviridae family, with 16 different 
genotypes5. In Colombia, the identified genotypes are V1, V3, V4, V5 and V8; 
genotype V1 is found in canines and eventually in bovines and equines, genotype 
V8 in skunks and V3 in bats, canines and cats3. Human contagion usually occurs 
through contact with infected saliva from dogs and cats, but numerous other animals 
have been implicated, including cattle and non-human primates. 
Rabies is usually transmitted by the infected saliva of a canine, feline or wild 
animal (haematophagus bat, primate, fox or bovine) to humans, and dogs are the 
main urban transmitters. However, there are other ways of transmission as the 
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contact between continuity solutions and infected corporal 
liquids, mucous contact with the virus, and in extreme 
circumstances, contact with aerosols containing high 
quantities of viruses in institutional laboratories6.
The main transmission pathway involves the contact 
between infected saliva and neuromuscular junctions. The 
incubation period varies between 1 and 3 months, but may 
range from 5 days to 6 or 12 months. This long latency 
period is explained by the low replication rate of the virus. 
Propagation depends on the amount of the inoculum and 
the tissue tropism. In bites that involve muscles, the virus 
is propagated in a centripetal way along motor axons, 
by transport vesicles, at a speed of 12 to 100 mm/day6-8. 
After the spinal cord motor neuron infection, the virus is 
transmitted to interneurons, proprioceptive neurons and 
dorsal root ganglia6,8. 
After this stage, a distance-dependent centrifuge 
propagation of the virus occurs, along with sensory and 
visceral nervous pathways. Anterograde axonal transport 
of the virus is inefficient, and takes weeks to arrive to 
extra neural organs, but explains multi-organ failure and 
dysautonomic symptoms on patients with rabies8,9.
Two types of clinical manifestations of rabies are 
typically described: paralytic and furious rabies. Furious 
rabies is characterized by the presentation of vegetative 
symptoms, behavioral changes, hydrophobia, aerophobia 
and paresthesias, typically presenting on the bitten limb. 
Conversely, paralytic rabies presents typically ascendant 
weakness and peripheral sensitive symptoms that can lead 
to coma6,9.
Finally, after the virus has spread and has affected the 
central nervous system (specifically the brain stem), the 
final stage is the migration towards the inside of the salivary 
glands, where it replicates within acinar cells and is ready 
to be transmitted to the next host6.
The diagnosis must be confirmed with laboratory tests. 
Direct fluorescent antibody (DFA) test of brain tissues 
is the gold standard recommended by the World Health 
Organization10.
We present a fatal case of rabies encephalitis with extra-
neural manifestations leding to delayed diagnosis. 
 
CASE REPORT
A 25-year-old female university student came to our 
university hospital emergency department because she had 
fallen a week before and had injured her right arm. She also 
complained that she had been feeling dizzy and had nausea 
with a single emetic episode five days before. The family 
also referred behavioral changes, incoherent language and 
episodes of agitation. This was the fourth time that she had 
consulted emergency departments in the past five days. 
Arm fractures had been ruled out; her dizziness had been 
attributed to otitis and she had been prescribed naproxen. 
In another occasion, she was diagnosed with an anxiety 
disorder and received sertraline and trazodone, which she 
took for only two days but suspended them because of an 
episode of urinary incontinence. In the last few hours she 
had developed a respiratory distress and fever. 
On physical examination she was anxious, but oriented 
and alert. Her body temperature was 38.5 °C. The most 
striking finding was a bilateral supraclavicular subcutaneous 
emphysema. Her blood count showed leukocytosis 
(17,100/mm3), with neutrophilia and monocytosis 
(1,300/mm3), urine, kidney and liver tests were 
normal; she had prolonged coagulation times and 
hyperlactatemia. The chest radiograph showed the presence 
of pneumomediastinum and supraclavicular subcutaneous 
emphysema (Figure 1). The general surgeon ordered a chest 
CT scan to rule out esophageal perforation; the exam showed 
signs of an infectious bronchiolitis of the right lower lobe 
and pneumonia of the medial segment of the middle lobe 
(Figure 2). Six hours after admission the patient presented 
a clinical respiratory deterioration with desaturation 
(60%), behavioral changes and somnolence. Suspecting 
a central nervous system infection, an antibiotic coverage 
was empirically initiated with ceftriaxone, vancomycin, 
ampicillin and dexamethasone. After diagnosing an acute 
adult respiratory distress syndrome (ARDS), she was 
intubated and oseltamivir was empirically initiated to treat 
a probable severe respiratory viral infection. HIV test was 
non-reactive, the cerebrospinal fluid (CSF) had a normal 
appearance, 2 leukocytes and 10 red blood cells per mm3 
with elevated proteins (64 mg/dL); film array tests for 
meningitis were negative (Kit Bio Fire, Salt Lake City, 
Utah, USA). Viral screening tests were negative (herpes 
virus family, enterovirus and cytomegalovirus). Given these 
results, both antibiotics and oseltamivir were interrupted. 
There was radiological improvement of ARDS, but her 
neurological condition deteriorated up to the absence of 
brain stem reflexes (even without sedation). A right Horner 
syndrome (oculosympathetic paresis) was then noticed. 
Brain CT scan was normal. Electroencephalography (EEG) 
showed dysynchronic activity (Figure 3). 
On day 2 of hospitalization, a government public 
health official, called after notification of a probable case 
of severe respiratory viral infection, conducted a detailed 
interrogation of the patient’s family members. They 
informed that she had been bitten on her right hand by a 
stray cat a month earlier. The cat had been captured and 
taken to a veterinarian who sacrificed the animal, without 
any further analysis. She had then complaint of paresthesias 
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on her right arm that resolved spontaneously. At that 
moment, with a potential diagnosis of rabies encephalitis, 
the Milwaukee protocol was initiated. Both serum and 
CSF IgM antibodies were negative for rabies. On day 3 the 
patient presented dysautonomia, hemodynamic instability 
and died. Necropsy reported Negri bodies on cerebellum 
Purkinje cells by histopathology, a direct fluorescent 
antibody test was positive for rabies virus, and irreversible 
brain injury secondary to possible infection by rabies virus 
leading to severe encephalitis, respiratory failure and death. 
 
DISCUSSION
This case of human rabies is secondary to a cat bite 
that occurred in a rural area (La Mesa) located 54 km 
from Colombia’s capital, Bogota. It was characterized by 
a typical neurological presentation as rabies encephalitis 
and extra-neural impairment given by the ARDS-like 
Figure 1 - A) Chest X-ray taken on admission shows the presence of subcutaneous emphysema; B) Chest X-ray taken six hours 
after admission showing pulmonary edema suggestive of acute respiratory distress syndrome.
Figure 2 - Thorax CT scan showing the presence of infectious 
bronchiolitis in the right inferior lobe and of pneumonia in the 
medial segment of the medial lobe (dotted arrow) associated 
to pericardial emphysema (bold arrow).
Figure 3 - Electroencephalographic (EEG) registration made while the patient was in coma, under mechanical controlled ventilation 
and intensive monitoring. Predominantly in frontocentral areas alpha activity (arrows) at 10 cycles is seen with a 25 millivolts 
amplitude mixed with a diffuse beta rhythm with low amplitude is shown (alpha).
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manifestations and subcutaneous emphysema. The latter 
was a confounding factor during early times after the onset 
of symptoms, aggravated by the delayed information of 
zoonotic exposure, by the family and the veterinarian. 
In Colombia, rabies is in the list of notifiable diseases, 
both in animal and human populations and inadequate 
management of this information can lead to underreporting 
of the disease and failure to implement individual and 
collective actions to prevent and treat human affected beings 
or at high risk of rabies virus infection3. 
Preventive measures include washing the wound with 
detergent; if the suspected animal will not be further 
observed, rabies vaccination should be performed. In cases 
with severe exposure presented by bites of animals with 
symptoms of rabies, both vaccination and application of 
rabies serum are indicated3.
The so-called “furious” type rabies encephalitis 
frequently presents as a clinical syndrome with unspecific 
symptoms such as fever, nausea, vomiting, asthenia, 
adynamia, weakness and pharyngeal pain, sometimes with 
paresthesias and itching on the affected limb. Behavioral 
symptoms, psychomotor agitation, seizures and fluctuations 
of consciousness may also be present7-9. There are some 
specific signs such as hydrophobia and aerophobia, that 
are not always present, are produced by phobic spams and 
present as progressive symptoms. On the EEG, dissociation 
between the electrophysiological activity and the clinical 
coma secondary to an anterior denervation of the brainstem 
can be seen, as described in our patient11,12. Alpha cortical 
activity can be found (alpha coma), suggesting a greater 
impairment of the diencephalon and brain stem. This pattern 
is explained by the physiopathology of the disease; the 
virus has an increased tropism for the basal and brainstem 
structures than for the cerebral cortex11,12. 
Extra-neural involvement has been frequently 
documented in salivary glands and skin, nonetheless, 
cardiac, pulmonary, hepatic and renal impairment have 
been described in a smaller proportion of patients. In studies 
carried out in mice models, extra-neural manifestations 
(including ARDS) are explained by localized inflammatory 
responses, macrophages proliferation and increased in nitric 
oxide synthase levels. ARDS in patients with rabies has 
been explained as an extra-neural inflammation due to a 
longer disease duration and a higher replication of viruses, 
therefore, further in this field is still needed13.
In spite of the aggressive therapeutic attempts, human 
rabies is still a fatal disease4,14. Survival in cases with some 
neurological sequels have been reported, probably related 
to early development of neutralizing antibodies against the 
virus, which happens in a small proportion of patients15. 
The Milwaukee protocol was published in 200315. 
It includes vaccination, anti-rabies immunoglobulin 
administration, ribavirine, alpha-interferon and ketamine 
administration16-18. This therapeutic schedule was used 
for the first time in a 15-year old girl in Wisconsin who 
had been bitten a month earlier by a bat and had not been 
vaccinated. She received a continuous ketamine infusion 
(48 mg/kg/day), intravenous antiretroviral therapy with 
ribavirin, amantadine 200 mg/kg/day and was submitted 
to an induced coma with midazolam and phenobarbital 
infusions18,19. Even though the patient survived with mild 
neurological sequels, the outcome of the patient has not 
been sufficiently explained. After the first publication of 
the protocol, there have been additional case reports with 
treatment failure18. 
CONCLUSION
Rabies is a zoonotic disease with a high mortality rate. It 
requires an early detection and prophylaxis in order to reduce 
viral replication. So far, there is not an effective treatment. 
However, vaccination and rabies serum administration are 
preventive options in exposed patients who have not yet 
developed symptoms. Information disclosure to the general 
population is essential since delay in contacting the health 
system may have serious consequences.
Ongoing research on viral pathogenesis is required in 
order to find new therapies for the disease. Extra-neural 
manifestations, like ARDS, subcutaneous emphysema, and 
others can be present in patients with history of exposure 
to wild or domestic animals presenting rabies, and should 
be considered in the differential diagnosis. 
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